<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induces calpain-mediated degradation of the neuronal cytoskeleton, alpha-fodrin, and this results in ischemic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the spatial distribution and temporal changes of calpain-catalyzed alpha-fodrin proteolysis in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and examined the effects of a calpain inhibitor </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> was induced in gerbils by 3-h middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Animals were divided into four groups: a sham-operated group, an ischemic group, a vehicle-treated group, and a calpain inhibitor-treated group </plain></SENT>
<SENT sid="4" pm="."><plain>Intravenous injections of vehicle or calpain inhibitor I were administered 30 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volumes were measured 1 day after reperfusion and the spatial distribution of calpain-catalyzed alpha-fodrin proteolysis was investigated by immunohistochemistry 15 min, 1 h, 4 h, and 1 day after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume (mean +/- SD) in the ischemic group and the vehicle-treated group was 204.6 +/- 19.1 mm3 and 212.4 +/- 16.3 mm3, respectively, and the calpain inhibitor I reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume [149.4 +/- 25.2 mm3 (P &lt; 0.05)] </plain></SENT>
<SENT sid="7" pm="."><plain>Immunoblot analysis demonstrated that calpain inhibitor reduced proteolysis </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> induced fodrin proteolysis in the ischemic core and the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> zone within 15 min after reperfusion, with proteolysis developing quickly in the ischemic core and more slowly in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> zone </plain></SENT>
<SENT sid="9" pm="."><plain>Proteolysis preceded neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> zone </plain></SENT>
<SENT sid="10" pm="."><plain>Calpain inhibitor I ameliorated neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> zone but not in the ischemic core </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, calpain plays a pivotal role on focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> as well as in global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>